Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Neurogene (NGNE) Profit After Tax (2018 - 2025)

Neurogene's Profit After Tax history spans 6 years, with the latest figure at -$24.8 million for Q4 2025.

  • For Q4 2025, Profit After Tax fell 26.89% year-over-year to -$24.8 million; the TTM value through Dec 2025 reached -$90.4 million, down 20.28%, while the annual FY2025 figure was -$90.4 million, 20.3% down from the prior year.
  • Profit After Tax reached -$24.8 million in Q4 2025 per NGNE's latest filing, down from -$21.0 million in the prior quarter.
  • In the past five years, Profit After Tax ranged from a high of $13.7 million in Q4 2023 to a low of -$24.8 million in Q4 2025.
  • Average Profit After Tax over 3 years is -$15.9 million, with a median of -$19.0 million recorded in 2024.
  • Peak YoY movement for Profit After Tax: plummeted 243.14% in 2024, then decreased 3.64% in 2025.
  • A 3-year view of Profit After Tax shows it stood at $13.7 million in 2023, then tumbled by 243.14% to -$19.5 million in 2024, then decreased by 26.89% to -$24.8 million in 2025.
  • Per Business Quant, the three most recent readings for NGNE's Profit After Tax are -$24.8 million (Q4 2025), -$21.0 million (Q3 2025), and -$22.0 million (Q2 2025).